跳至主要内容
临床试验/NL-OMON43024
NL-OMON43024招募中不适用

Correlation between symptoms and the presence of gluten immunogenic peptides in faeces and urine after single dose gluten provocation in patients with coeliac disease* - Gluten intake, symptoms and detection of gluten in urine and feces

Rijnstate Ziekenhuis0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with biopsy proven coeliac disease, Marsh IIIA or higher at time of diagnosis, adhering to a gluten-free diet and aged 18 years or older are eligible if:
  • - They report clear symptoms on gluten exposure
  • - They report excellent or no problems with dietary adherence (score 13 or less) on the Celiac Disease Adherence Test (CDAT)(8) (Appendix 2)
  • - They report scores resembling clinical remission (score 30 or less) on the Celiac Symptom Index (CSI)(9) (Appendix 3)
  • - Serum TTG and EMA levels are non-detectable during gluten-free diet
  • - Negative GIP in urine/ faeces at the start of this study

排除标准

  • Patients will be excluded if;
  • - They report other CDAT and/or CSI scores
  • - They are pregnant
  • - They have known gastroenterological co-morbidity
  • - They have malignant disease
  • - They use painkillers or other drugs to reduce symptoms

研究者

发起方
Rijnstate Ziekenhuis

相似试验